Data Clock Korea
Browse data
Health

Cancer Registration Statistics (1/4)

2 tables and 141 items from the KOSIS survey “Cancer Registration Statistics”, as annual figures and charts.

24개 암종/성별 암발생자수, 상대빈도, 조발생률, 연령표준화발생률

Back to top

성별 계 · 24개 암종별 모든 암(C00-C96)

All Cancers (C00-C96) Case

1999 101,854person→2023 288,613person▲ +183.4%

Lip oral cavity and pharynx (C00-C14) Case

1999 1,741person→2023 4,834person▲ +177.7%

Esophagus (C15) Case

1999 1,861person→2023 3,142person▲ +68.8%

Stomach (C16) Case

1999 20,900person→2023 28,943person▲ +38.5%

Colon and rectum (C18-C20) Case

1999 9,783person→2023 32,610person▲ +233.3%

Liver (C22) Case

1999 13,263person→2023 14,707person▲ +10.9%

Gallbladder etc. (C23-C24) Case

1999 3,047person→2023 7,997person▲ +162.5%

Pancreas (C25) Case

1999 2,614person→2023 9,748person▲ +272.9%

Larynx (C32) Case

1999 1,101person→2023 1,254person▲ +13.9%

Lung (C33-C34) Case

1999 13,224person→2023 32,953person▲ +149.2%

Breast (C50) Case

1999 5,888person→2023 29,871person▲ +407.3%

Cervix uteri (C53) Case

1999 4,486person→2023 3,144person▼ −29.9%

Corpus uteri (C54) Case

1999 728person→2023 4,037person▲ +454.5%

Ovary (C56) Case

1999 1,354person→2023 3,299person▲ +143.6%

Prostate (C61) Case

1999 1,454person→2023 22,640person▲ +1457.1%

Testis (C62) Case

1999 129person→2023 315person▲ +144.2%

Kidney (C64) Case

1999 1,416person→2023 7,367person▲ +420.3%

Bladder (C67) Case

1999 2,195person→2023 5,545person▲ +152.6%

Brain ＆ CNS (C70-C72) Case

1999 1,359person→2023 2,080person▲ +53.1%

Thyroid (C73) Case

1999 3,407person→2023 35,440person▲ +940.2%

Hodgkin disease (C81) Case

1999 122person→2023 356person▲ +191.8%

Non-Hodgkin lymphoma (C82-C86 C96) Case

1999 2,064person→2023 6,109person▲ +196.0%

Multiple myeloma (C90) Case

1999 468person→2023 2,099person▲ +348.5%

Leukemia (C91-C95) Case

1999 2,168person→2023 4,218person▲ +94.6%

Lip oral cavity and pharynx (C00-C14) Percent

1999 1.7%→2023 1.7%▲ +0.0%

Esophagus (C15) Percent

1999 1.8%→2023 1.1%▼ −38.9%

Stomach (C16) Percent

1999 20.5%→2023 10%▼ −51.2%

Colon and rectum (C18-C20) Percent

1999 9.6%→2023 11.3%▲ +17.7%

Liver (C22) Percent

1999 13%→2023 5.1%▼ −60.8%

Gallbladder etc. (C23-C24) Percent

1999 3%→2023 2.8%▼ −6.7%

Pancreas (C25) Percent

1999 2.6%→2023 3.4%▲ +30.8%

Larynx (C32) Percent

1999 1.1%→2023 0.4%▼ −63.6%

Lung (C33-C34) Percent

1999 13%→2023 11.4%▼ −12.3%

Breast (C50) Percent

1999 5.8%→2023 10.3%▲ +77.6%

Cervix uteri (C53) Percent

1999 4.4%→2023 1.1%▼ −75.0%

Corpus uteri (C54) Percent

1999 0.7%→2023 1.4%▲ +100.0%

Ovary (C56) Percent

1999 1.3%→2023 1.1%▼ −15.4%

Prostate (C61) Percent

1999 1.4%→2023 7.8%▲ +457.1%

Kidney (C64) Percent

1999 1.4%→2023 2.6%▲ +85.7%

Bladder (C67) Percent

1999 2.2%→2023 1.9%▼ −13.6%

Brain ＆ CNS (C70-C72) Percent

1999 1.3%→2023 0.7%▼ −46.2%

Thyroid (C73) Percent

1999 3.3%→2023 12.3%▲ +272.7%

Non-Hodgkin lymphoma (C82-C86 C96) Percent

1999 2%→2023 2.1%▲ +5.0%

Multiple myeloma (C90) Percent

1999 0.5%→2023 0.7%▲ +40.0%

Leukemia (C91-C95) Percent

1999 2.1%→2023 1.5%▼ −28.6%

All Cancers (C00-C96) Crude Rate

1999 216rate per 100000→2023 564rate per 100000▲ +161.2%

Lip oral cavity and pharynx (C00-C14) Crude Rate

1999 3.7rate per 100000→2023 9.5rate per 100000▲ +156.8%

Esophagus (C15) Crude Rate

1999 3.9rate per 100000→2023 6.1rate per 100000▲ +56.4%

Stomach (C16) Crude Rate

1999 44.3rate per 100000→2023 56.6rate per 100000▲ +27.8%

Colon and rectum (C18-C20) Crude Rate

1999 20.7rate per 100000→2023 63.8rate per 100000▲ +208.2%

Liver (C22) Crude Rate

1999 28.1rate per 100000→2023 28.8rate per 100000▲ +2.5%

Gallbladder etc. (C23-C24) Crude Rate

1999 6.5rate per 100000→2023 15.6rate per 100000▲ +140.0%

Pancreas (C25) Crude Rate

1999 5.5rate per 100000→2023 19.1rate per 100000▲ +247.3%

Larynx (C32) Crude Rate

1999 2.3rate per 100000→2023 2.5rate per 100000▲ +8.7%

Lung (C33-C34) Crude Rate

1999 28rate per 100000→2023 64.4rate per 100000▲ +130.0%

Breast (C50) Crude Rate

1999 12.5rate per 100000→2023 58.4rate per 100000▲ +367.2%

Cervix uteri (C53) Crude Rate

1999 9.5rate per 100000→2023 6.1rate per 100000▼ −35.8%

Corpus uteri (C54) Crude Rate

1999 1.5rate per 100000→2023 7.9rate per 100000▲ +426.7%

Ovary (C56) Crude Rate

1999 2.9rate per 100000→2023 6.5rate per 100000▲ +124.1%

Prostate (C61) Crude Rate

1999 3.1rate per 100000→2023 44.3rate per 100000▲ +1329.0%

Testis (C62) Crude Rate

1999 0.3rate per 100000→2023 0.6rate per 100000▲ +100.0%

Kidney (C64) Crude Rate

1999 3rate per 100000→2023 14.4rate per 100000▲ +380.0%

Bladder (C67) Crude Rate

1999 4.7rate per 100000→2023 10.8rate per 100000▲ +129.8%

Brain ＆ CNS (C70-C72) Crude Rate

1999 2.9rate per 100000→2023 4.1rate per 100000▲ +41.4%

Thyroid (C73) Crude Rate

1999 7.2rate per 100000→2023 69.3rate per 100000▲ +862.5%

Hodgkin disease (C81) Crude Rate

1999 0.3rate per 100000→2023 0.7rate per 100000▲ +133.3%

Non-Hodgkin lymphoma (C82-C86 C96) Crude Rate

1999 4.4rate per 100000→2023 11.9rate per 100000▲ +170.5%

Multiple myeloma (C90) Crude Rate

1999 1rate per 100000→2023 4.1rate per 100000▲ +310.0%

Leukemia (C91-C95) Crude Rate

1999 4.6rate per 100000→2023 8.2rate per 100000▲ +78.3%

All Cancers (C00-C96) Age-Standardized Rate

1999 403rate per 100000→2023 523rate per 100000▲ +29.8%

Lip oral cavity and pharynx (C00-C14) Age-Standardized Rate

1999 6.6rate per 100000→2023 8.8rate per 100000▲ +33.3%

Esophagus (C15) Age-Standardized Rate

1999 8.2rate per 100000→2023 5.5rate per 100000▼ −32.9%

Stomach (C16) Age-Standardized Rate

1999 86rate per 100000→2023 51.4rate per 100000▼ −40.2%

Colon and rectum (C18-C20) Age-Standardized Rate

1999 40.8rate per 100000→2023 58.7rate per 100000▲ +43.9%

Liver (C22) Age-Standardized Rate

1999 52.4rate per 100000→2023 26.1rate per 100000▼ −50.2%

Gallbladder etc. (C23-C24) Age-Standardized Rate

1999 14rate per 100000→2023 13.8rate per 100000▼ −1.4%

Pancreas (C25) Age-Standardized Rate

1999 11.7rate per 100000→2023 17.1rate per 100000▲ +46.2%

Larynx (C32) Age-Standardized Rate

1999 4.8rate per 100000→2023 2.2rate per 100000▼ −54.2%

Lung (C33-C34) Age-Standardized Rate

1999 59.8rate per 100000→2023 57.5rate per 100000▼ −3.8%

Breast (C50) Age-Standardized Rate

1999 17.2rate per 100000→2023 56.8rate per 100000▲ +230.2%

Cervix uteri (C53) Age-Standardized Rate

1999 14.2rate per 100000→2023 5.9rate per 100000▼ −58.5%

Corpus uteri (C54) Age-Standardized Rate

1999 2.4rate per 100000→2023 7.6rate per 100000▲ +216.7%

Ovary (C56) Age-Standardized Rate

1999 4.5rate per 100000→2023 6.2rate per 100000▲ +37.8%

Prostate (C61) Age-Standardized Rate

1999 7.4rate per 100000→2023 39.2rate per 100000▲ +429.7%

Testis (C62) Age-Standardized Rate

1999 0.2rate per 100000→2023 0.6rate per 100000▲ +200.0%

Kidney (C64) Age-Standardized Rate

1999 5.3rate per 100000→2023 13.5rate per 100000▲ +154.7%

Bladder (C67) Age-Standardized Rate

1999 9.8rate per 100000→2023 9.6rate per 100000▼ −2.0%

Brain ＆ CNS (C70-C72) Age-Standardized Rate

1999 4.1rate per 100000→2023 3.9rate per 100000▼ −4.9%

Thyroid (C73) Age-Standardized Rate

1999 9.8rate per 100000→2023 68.9rate per 100000▲ +603.1%

Hodgkin disease (C81) Age-Standardized Rate

1999 0.3rate per 100000→2023 0.7rate per 100000▲ +133.3%

Non-Hodgkin lymphoma (C82-C86 C96) Age-Standardized Rate

1999 7.1rate per 100000→2023 11.1rate per 100000▲ +56.3%

Multiple myeloma (C90) Age-Standardized Rate

1999 1.9rate per 100000→2023 3.7rate per 100000▲ +94.7%

Leukemia (C91-C95) Age-Standardized Rate

1999 6.1rate per 100000→2023 7.8rate per 100000▲ +27.9%

24개 암종/성/연령(5세)별 암발생자수, 발생률

Back to top

24개 암종별 모든 암(C00-C96) · 성별 계 · 연령별 계

All Cancers (C00-C96) Case

1999 101,854person→2023 288,613person▲ +183.4%

Lip oral cavity and pharynx (C00-C14) Case

1999 1,741person→2023 4,834person▲ +177.7%

Esophagus (C15) Case

1999 1,861person→2023 3,142person▲ +68.8%

Stomach (C16) Case

1999 20,900person→2023 28,943person▲ +38.5%

Colon and rectum (C18-C20) Case

1999 9,783person→2023 32,610person▲ +233.3%

Liver (C22) Case

1999 13,263person→2023 14,707person▲ +10.9%

Gallbladder etc. (C23-C24) Case

1999 3,047person→2023 7,997person▲ +162.5%

Pancreas (C25) Case

1999 2,614person→2023 9,748person▲ +272.9%

Larynx (C32) Case

1999 1,101person→2023 1,254person▲ +13.9%

Lung (C33-C34) Case

1999 13,224person→2023 32,953person▲ +149.2%

Breast (C50) Case

1999 5,888person→2023 29,871person▲ +407.3%

Cervix uteri (C53) Case

1999 4,486person→2023 3,144person▼ −29.9%

Corpus uteri (C54) Case

1999 728person→2023 4,037person▲ +454.5%

Ovary (C56) Case

1999 1,354person→2023 3,299person▲ +143.6%

Prostate (C61) Case

1999 1,454person→2023 22,640person▲ +1457.1%

Testis (C62) Case

1999 129person→2023 315person▲ +144.2%

Kidney (C64) Case

1999 1,416person→2023 7,367person▲ +420.3%

Bladder (C67) Case

1999 2,195person→2023 5,545person▲ +152.6%

Brain ＆ CNS (C70-C72) Case

1999 1,359person→2023 2,080person▲ +53.1%

Thyroid (C73) Case

1999 3,407person→2023 35,440person▲ +940.2%

Hodgkin disease (C81) Case

1999 122person→2023 356person▲ +191.8%

Non-Hodgkin lymphoma (C82-C86 C96) Case

1999 2,064person→2023 6,109person▲ +196.0%

Multiple myeloma (C90) Case

1999 468person→2023 2,099person▲ +348.5%

Leukemia (C91-C95) Case

1999 2,168person→2023 4,218person▲ +94.6%

All Cancers (C00-C96) Age-Specific Rate

1999 216rate per 100000→2023 564rate per 100000▲ +161.2%

Lip oral cavity and pharynx (C00-C14) Age-Specific Rate

1999 3.7rate per 100000→2023 9.5rate per 100000▲ +156.8%

Esophagus (C15) Age-Specific Rate

1999 3.9rate per 100000→2023 6.1rate per 100000▲ +56.4%

Stomach (C16) Age-Specific Rate

1999 44.3rate per 100000→2023 56.6rate per 100000▲ +27.8%

Colon and rectum (C18-C20) Age-Specific Rate

1999 20.7rate per 100000→2023 63.8rate per 100000▲ +208.2%

Liver (C22) Age-Specific Rate

1999 28.1rate per 100000→2023 28.8rate per 100000▲ +2.5%

Gallbladder etc. (C23-C24) Age-Specific Rate

1999 6.5rate per 100000→2023 15.6rate per 100000▲ +140.0%

Pancreas (C25) Age-Specific Rate

1999 5.5rate per 100000→2023 19.1rate per 100000▲ +247.3%

Larynx (C32) Age-Specific Rate

1999 2.3rate per 100000→2023 2.5rate per 100000▲ +8.7%

Lung (C33-C34) Age-Specific Rate

1999 28rate per 100000→2023 64.4rate per 100000▲ +130.0%

Breast (C50) Age-Specific Rate

1999 12.5rate per 100000→2023 58.4rate per 100000▲ +367.2%

Cervix uteri (C53) Age-Specific Rate

1999 9.5rate per 100000→2023 6.1rate per 100000▼ −35.8%

Corpus uteri (C54) Age-Specific Rate

1999 1.5rate per 100000→2023 7.9rate per 100000▲ +426.7%

Ovary (C56) Age-Specific Rate

1999 2.9rate per 100000→2023 6.5rate per 100000▲ +124.1%

Prostate (C61) Age-Specific Rate

1999 3.1rate per 100000→2023 44.3rate per 100000▲ +1329.0%

Testis (C62) Age-Specific Rate

1999 0.3rate per 100000→2023 0.6rate per 100000▲ +100.0%

Kidney (C64) Age-Specific Rate

1999 3rate per 100000→2023 14.4rate per 100000▲ +380.0%

Bladder (C67) Age-Specific Rate

1999 4.7rate per 100000→2023 10.8rate per 100000▲ +129.8%

Brain ＆ CNS (C70-C72) Age-Specific Rate

1999 2.9rate per 100000→2023 4.1rate per 100000▲ +41.4%

Thyroid (C73) Age-Specific Rate

1999 7.2rate per 100000→2023 69.3rate per 100000▲ +862.5%

Hodgkin disease (C81) Age-Specific Rate

1999 0.3rate per 100000→2023 0.7rate per 100000▲ +133.3%

Non-Hodgkin lymphoma (C82-C86 C96) Age-Specific Rate

1999 4.4rate per 100000→2023 11.9rate per 100000▲ +170.5%

Multiple myeloma (C90) Age-Specific Rate

1999 1rate per 100000→2023 4.1rate per 100000▲ +310.0%

Leukemia (C91-C95) Age-Specific Rate

1999 4.6rate per 100000→2023 8.2rate per 100000▲ +78.3%

Data source

Organization
기관 117
Dataset
24개 암종/성별 암발생자수, 상대빈도, 조발생률, 연령표준화발생률
Provider
KOSIS 국가통계포털
Period
1999 ~ 2023
As of
2026-08-29
Processing
KOSIS OpenAPI 로 연간 전국값을 받아 그대로 사용. 가공 없음.
원천 데이터 보기 →

Other surveys in this category